Enzon Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $98,000 over the previous period. Total operating expenses were $1,044,000.
Profit Margin
| 2014 | 31.17M | 28.79M | 92.37% |
|---|---|---|---|
| 2015 | 17.45M | 21.63M | 123.95% |
| 2016 | 8.37M | -1.12M | -13.44% |
| 2017 | 8.37M | 5.44M | 64.98% |
| 2018 | 6.91M | 5.84M | 84.55% |
| 2019 | 207K | -979K | -472.95% |
| 2020 | 52K | -1.31M | -2521.15% |
| 2021 | 701K | -469K | -66.9% |
| 2022 | 26K | -186K | -715.38% |
| 2023 | 0 | 98K |
ENZN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 26K | 701K | 52K | 207K | 6.91M | 8.37M | 8.37M | 17.45M | 31.17M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 26K | 701K | 52K | 207K | 6.91M | 8.37M | 8.37M | 17.45M | 31.17M |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.04M | 1.05M | 1.17M | 1.35M | 1.18M | 1.06M | 1.37M | 1.67M | 2.15M | 2.38M |
Operating income | -1.04M | -1.03M | -469K | -1.30M | -973K | 5.85M | 7.00M | 6.64M | 10.8M | 28.79M |
Other income (expenses), net | 2.26M | 646K | 7K | 1K | 0 | 0 | 0 | -54K | 0 | 61K |
Income before tax | 1.21M | -386K | -462K | -1.30M | -973K | 5.85M | 7.00M | 6.64M | 10.8M | 28.85M |
Income tax expense | -156K | -200K | 7K | 7K | 6K | 6K | 1.56M | 7.77M | -10.83M | 56K |
Net income | 98K | -186K | -469K | -1.31M | -979K | 5.84M | 5.44M | -1.12M | 21.63M | 28.79M |
Earnings per share | ||||||||||
Basic EPS | 0.00 | -0.00 | -0.00 | -0.02 | -0.02 | 0.13 | 0.12 | -0.02 | 0.49 | 0.65 |
Diluted EPS | 0.00 | -0.00 | -0.00 | -0.02 | -0.02 | 0.13 | 0.12 | -0.02 | 0.49 | 0.65 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |